Tevogen Inc. (TVGN) Form SCHEDULE 13D/A — Nov 4, 2026
Tevogen CEO Ryan Saadi filed a Schedule 13D/A disclosing a grant of 50,000,000 restricted shares on November 2, 2026 under the company's 2024 Omnibus Incentive Plan, lifting his beneficial ownership to 61,709,567 shares, or 91.1% of the common stock. The award vests only if the Board certifies $1.0 billion in aggregate revenue between November 2, 2026 and December 31, 2031; otherwise the shares are automatically forfeited, as they are upon termination of service or certain misconduct.
Key figures
- Percent Owned
- 91.1%
- Shares Granted
- 50000000
- Revenue Threshold
- $1.0 billion aggregate revenue
- Performance Period
- November 2, 2026 through December 31, 2031
- Aggregate Shares Owned
- 61709567
- Sole voting power
- 61705689
- Sole dispositive power
- 1938710
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.